Open AccessCombination therapy with methadone and duloxetine for cancer-related pain: a retrospective study
Author(s) -
Zachary A. Curry,
Malisa Dang,
Adam Šíma,
Sura Abdullaziz,
Egidio Del Fabbro
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-20-1455
Subject(s) - medicine , duloxetine , methadone , cancer pain , retrospective cohort study , cancer , oncology , anesthesia , alternative medicine , pathology
A comprehensive approach to pain management often requires multimodal therapy and a combination of medications. Oncology patients may be prescribed methadone and duloxetine as single agents or in combination for cancer-related pain, particularly neuropathic pain. Duloxetine is also prescribed for depression or anxiety in patients with cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom